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Abstract 22 
A pulsatile pattern of secretion is a characteristic of many hormonal systems, 23 
including the glucocorticoid-producing hypothalamic-pituitary-adrenal axis. Despite 24 
recent evidences supporting its importance for behavioral, neuroendocrine and 25 
transcriptional effects of glucocorticoids, there has been a paucity of information 26 
regarding the origin of glucocorticoid pulsatility. In this review we discuss how CORT 27 
pulsatility is generated, what are the mechanisms regulating the dynamics of the 28 
HPA axis, and how these dynamics become disrupted in disease. Our recent 29 
mathematical, experimental and clinical studies show that glucocorticoid pulsatility is 30 
generated and maintained by dynamic processes at the level of the pituitary-adrenal 31 
axis, and that an intra-adrenal negative feedback may contribute to these dynamics. 32 
We also describe how these dynamics may become disrupted in conditions of 33 
disease and critical illness. 34 
  35 
Introduction 36 
Glucocorticoids, the end product of the hypothalamic-pituitary-adrenal (HPA) axis, 37 
are essential hormones that regulate the organism's homeostasis and its response to 38 
stress. Glucocorticoids (corticosterone in the rat, cortisol in humans, here referred to 39 
as CORT) are synthetized in the adrenal gland cortex in response to 40 
adrenocorticotropic hormone (ACTH) release from corticotroph cells in the anterior 41 
pituitary. ACTH secretion is in turn regulated by the release of the neuropeptides 42 
corticotropin releasing hormone (CRH) and arginine vasopressin (AVP) from the 43 
paraventricular nucleus of the hypothalamus (PVN). Upon release from the adrenal 44 
glands into the general circulation, CORT exerts its effects by binding specific 45 
receptors, the glucocorticoid and mineralocorticoid receptors (GR and MR, 46 
respectively), which are widely expressed in target organs throughout the body. In 47 
addition to its metabolic, cardiovascular, immune-suppressive and anti-inflammatory 48 
effects, to name a few, CORT also regulates its own production through negative 49 
feedback mechanisms within the HPA axis that include the inhibition of synthesis and 50 
release of ACTH from the anterior pituitary (Jones, et al. 1977), and, to a lesser 51 
extent, inhibition of CRH by direct modulation of neuronal activity both in the PVN as 52 
well as other brain structures, including the hippocampus, amygdala and prefrontal 53 
cortex, which regulate the activity of the PVN (Dallman, et al. 1987a; Dallman, et al. 54 
1987b; Jones et al. 1977; Ulrich-Lai and Herman 2009) (Figure 1a). 55 
 56 
Ultradian rhythm of the HPA axis 57 
Under basal (i.e., unstressed) conditions the secretion of CORT over the course of 58 
the day is not constant but is characterized by a circadian pattern with hormone 59 
levels peaking during the active phase of the animal. In addition to this, studies in 60 
several species, including the rat and human, have revealed that CORT is released 61 
dynamically from the adrenal gland (Jasper and Engeland, 1991; 1994), resulting in 62 
an ultradian pulsatile rhythm in the blood (Windle, et al. 1998), as well as in target 63 
tissues, such as the brain (Droste, et al. 2009), and in subcutaneous tissue (Qian, et 64 
al. 2012). In the rat, CORT pulses have a nearly-hourly frequency and changes in the 65 
amplitude of these pulses throughout the 24-hour cycle determine the circadian 66 
variation of hormone secretion (Figure 1b).  67 
The ultradian rhythm of CORT is an important factor in determining the behavioral, 68 
neuroendocrine and genomic response to stressors. Furthermore, CORT pulsatility is 69 
crucial for physiological activation of GR and MR, and for optimal transcriptional 70 
responses of glucocorticoid-responsive genes. Because variation in both the 71 
amplitude and the frequency of CORT pulses occurs in a number of physiological 72 
and pathological conditions, including aging and chronic inflammatory disease 73 
(reviewed in (Spiga, et al. 2014)), these changes in the pattern of CORT release may 74 
be associated with the disrupted physiological functions observed in these 75 
conditions. The importance of pulsatility for genomic, behavioral and neuroendocrine 76 
responses to CORT has been described in great detail elsewhere (Spiga et al. 2014). 77 
The purpose of this review article is to discuss how CORT pulsatility is generated, 78 
what are the mechanisms regulating the dynamics of the HPA axis, and how these 79 
dynamics become disrupted in disease. To achieve this, we will review recent and 80 
innovative findings from mathematical, experimental and clinical studies. 81 
 82 
The origin of glucocorticoid pulsatility  83 
The circadian rhythm of the HPA axis is under the control of the suprachiasmatic 84 
nucleus (SCN), which directly regulates the pattern of CRH and AVP release from 85 
the PVN, and in addition modulates the responsiveness of the adrenal gland to 86 
ACTH via the autonomic nervous system and splanchnic nerve (reviewed in 87 
(Kalsbeek, et al. 2012)).  There has however been much less research into the 88 
mechanism underlying the ultradian rhythm of CORT, and how this rhythm is 89 
maintained at different levels of the HPA axis, despite the significant amount of data 90 
highlighting the importance of the ultradian rhythm for normal physiological 91 
responses. A recent study from our group has demonstrated that, while the circadian 92 
rhythm of ACTH and CORT is lost in rats in which the suprachiasmatic nucleus 93 
activity has been disrupted, the ultradian CORT pattern is maintained (Waite, et al. 94 
2012), providing strong evidence for a CORT ultradian pulse generator functioning 95 
independently of the SCN. This is also in accordance with data from Jasper and 96 
Engeland showing that lesioning of the splanchnic nerve results in dampened 97 
circadian CORT rhythmicity but sustained pulsatility in adrenal corticosterone 98 
secretion measured using intra-adrenal microdialysis techniques (Jasper and 99 
Engeland 1994). 100 
If the SCN does not control ultradian rhythmicity, could some other area of the 101 
hypothalamus be responsible as has been described for other pulsatile hormones 102 
such as secretion of luteinizing hormone and growth hormone. These hormones 103 
oscillate in response to the pulsatile secretion of hypothalamic gonadotropin-104 
releasing hormone (GnRH) (Belchetz, et al. 1978; Clarke and Cummins 1982; 105 
Plotsky and Vale 1985) whereas pulsatile release of growth hormone depends on 106 
pulsatile release of somatostatin and growth-hormone releasing hormone (Plotsky 107 
and Vale 1985)  108 
With respect to HPA axis rhythmicity, pulsatility of ACTH has been described in the 109 
rat (Carnes, et al. 1986; Carnes, et al. 1988a; Carnes, et al. 1988b), sheep 110 
(Apostolakis, et al. 1992), and human (Henley, et al. 2009a). Furthermore, episodic 111 
release of CRH has been shown in macaque (Mershon, et al. 1992), sheep (Caraty, 112 
et al. 1988; Engler, et al. 1989), and the rat (Ixart, et al. 1991; Ixart, et al. 1994). The 113 
evidence of pulsatility of CRH led to the acceptance that the ultradian release of 114 
CORT was likely to be dependent on the rhythm of a hypothalamic CRH pulse 115 
generator. There were however a number of discrepant findings that suggested this 116 
was not the case. For example, studies in the sheep have shown that ultradian 117 
rhythms of ACTH and CORT are maintained even after the hypothalamus has been 118 
surgically disconnected from the pituitary (Engler, et al. 1990), suggesting there must 119 
be a hypothalamic-independent pulse generator. To further support this idea is the 120 
observation that in the rat there is a mismatch between the frequency of CRH pulses 121 
(~3 pulses/h) (Ixart et al. 1991), and the near-hourly frequency of ACTH and CORT 122 
oscillations (Carnes et al. 1988a). 123 
Using a combination of mathematical modeling and in vivo experimental approaches, 124 
we have proposed that the pituitary-adrenal system possesses an endogenous 125 
oscillatory mechanism generating pulses of ACTH and CORT at a physiological 126 
ultradian frequency independent of pulsatile release of CRH and/or AVP from the 127 
PVN. This hypothesis is based on the knowledge that the activity of the pituitary-128 
adrenal system axis is governed by an ACTH-mediated positive feedforward pathway 129 
regulating adrenal synthesis and secretion of CORT, and by a CORT-mediated 130 
negative feedback that regulates ACTH secretion at the pituitary level. An important 131 
feature of this feedforward-feedback loop is the slightly delayed secretory response 132 
of the adrenal in response to ACTH stimulation that has been observed both in the 133 
rat (Carnes, et al. 1994; Walker, et al. 2012) and in humans (Henley et al. 2009a). 134 
This time delay of a few minutes is presumably due to the time needed by the 135 
adrenal for de novo synthesis CORT in response to ACTH, since in contrast to 136 
peptides hormones (e.g. CRH and ACTH), CORT cannot be pre-synthesized and 137 
stored within adrenal steroidogenic cells due to its lipophilic nature. Once released 138 
into the general circulation, CORT activates a fast (presumably non-genomic) 139 
negative feedback mechanism at the level of the pituitary that still remains to be fully 140 
characterized (Hinz and Hirschelmann 2000; Jones, et al. 1972; Jones, et al. 1974; 141 
Mahmoud, et al. 1984; Rotsztejn, et al. 1975a; Rotsztejn, et al. 1975b; Russell, et al. 142 
2010; Widmaier and Dallman 1984).  143 
 144 
Mathematical modeling of the pulse generator 145 
To investigate the dynamic interaction between the pituitary and the adrenal gland 146 
we have developed a mathematical model of differential equations incorporating the 147 
CRH acting on the pituitary, the time taken for CORT to be synthesized and secreted 148 
by the adrenal gland in response to ACTH stimulus, and the rapid CORT-mediated 149 
inhibition of ACTH secretion at the pituitary (Walker, et al. 2010). In addition, we 150 
made the assumption that CORT-driven inhibition of CRH is not important for this 151 
rapid effect, which is primarily at the level of the anterior pituitary. 152 
 153 
We have used the mathematical techniques of bifurcation analysis and numerical 154 
continuation to study the dynamical behaviour of this model (i.e. the dynamics of 155 
ACTH and CORT) (Walker et al. 2010). These techniques have allowed us to identify 156 
parameter values – in this case, levels of CRH and adrenal time delay – at which 157 
there is a qualitative change in the dynamics of the system (i.e. a bifurcation), and 158 
then “follow” this bifurcation through parameter space. This results in curves in 159 
parameter space that map out regions corresponding to qualitatively different system 160 
dynamics. 161 
 162 
In accordance with the hypothesis of a sub-hypothalamic pulse generator, we 163 
considered the model's response to constant levels of CRH drive. The model 164 
predicted that for certain “physiological” levels of constant CRH drive (e.g. during the 165 
circadian peak of HPA axis activity) the pituitary-adrenal system could support self-166 
sustained ACTH and CORT oscillations characterized by a physiological ultradian 167 
frequency (~1pulse/hour; Figure 2a). Furthermore, the model predicted that for either 168 
higher “stress-equivalent” levels, or lower “basal” levels of constant CRH, both ACTH 169 
and CORT oscillations become dampened, resulting in a steady-state response in 170 
hormone secretion—such responses have been observed in vivo following exposure 171 
to an acute stressor (high constant CRH), or at the circadian nadir of HPA axis 172 
activity (low constant CRH) (Windle et al. 1998).  173 
Interestingly, when a "physiological level" of pulsatile CRH (~3 pulses/hour) was 174 
imposed on the pituitary-adrenal system, the model predicted that the resulting 175 
frequency of ACTH and CORT oscillations (~1pulse/hour) would still be 176 
predominantly governed by the pituitary-adrenal interaction (Figure 2b), further 177 
supporting an independency of the CORT pulse generator from the dynamics of the 178 
hypothalamic drive. Furthermore, when a circadian pattern was imposed on the 179 
constant CRH drive, the resultant pattern of ACTH and CORT secretion displayed 180 
both circadian and ultradian rhythmicity, which is consistent with an SCN-driven CRH 181 
modulation of circadian, but not ultradian, CORT rhythm (Figure 2c).  182 
To test the validity of our modelling predictions we then used an experimental 183 
approach in vivo to investigate the dynamics of ACTH and CORT in response to 184 
different levels of constant CRH stimulation in conscious freely-behaving male rats 185 
(Walker et al. 2012). This approach has allowed us to confirm the predictions of our 186 
mathematical model, as we have been able to show ultradian ACTH and CORT 187 
oscillations can be induced by constant infusion of CRH, with resultant CORT pulse 188 
amplitude and frequency similar to that of endogenous pulses observed during the 189 
circadian peak of hormone release. Consistent with the model, we have also 190 
observed the expected time delay between pulses of ACTH and pulses of CORT. 191 
Furthermore, constant infusion of a higher dose of CRH resulted in an elevated and 192 
sustained level of CORT, similar to the pattern observed in response to severe 193 
stressors known to induce a robust increase in hypothalamic CRH secretion. 194 
In summary, both our modelling work and experimental data support the hypothesis 195 
of a self-sustained, sub-hypothalamic ACTH and CORT pulse generator that 196 
depends on the dynamic interaction between the anterior pituitary and the adrenal 197 
cortex.  198 
Our mathematical model also predicts that any disruption in the ACTH feedforward 199 
drive (i.e. adrenal delay) or in the CORT feedback mechanism within the pituitary 200 
could have an effect on the pulsatile dynamics of ACTH and CORT. Since ACTH is 201 
not the only factor that can influence CORT synthesis in the adrenal, it is clearly of 202 
interest to investigate how other factors such as pathogens and inflammatory-203 
mediators may interact with the physiological ACTH-mediated adrenal delay. Chronic 204 
inflammation in the rat is associated with changes in the pulsatile CORT pattern 205 
(Windle, et al. 2001). Furthermore, changes in CORT-mediated signalling at the level 206 
of the anterior pituitary can also affect CORT pulsatility and chronic administration of 207 
a GR antagonist leads to changes in ultradian rhythm of CORT with an increase in 208 
the number, height and frequency of CORT pulses, resulting in an overall increase in 209 
hormone levels trough the 24-h cycle, presumably as a result of an impaired GR-210 
mediated inhibition of ACTH secretion (Spiga, et al. 2007). 211 
 212 
Adrenal regulation of glucocorticoid pulsatility 213 
Studies in human and in the rat have shown that in addition to CORT, ACTH is also 214 
released in a pulsatile manner, with the ACTH pulse amplitude increasing throughout 215 
the day as result of the circadian input from the SCN, via regulation of circadian 216 
secretion of CRH (ref Alan watts). Given that pulsatility of CORT is important for 217 
maintaining optimal transcription of glucocorticoid regulated gene (Stavreva et al. 218 
2010), we thought to investigate whether pulsatile ACTH is important for optimal 219 
transcription of ACTH-responsive steroidogenic genes within the adrenal cortex. By 220 
using a model of suppressed endogenous ACTH secretion, we found that while the 221 
adrenal gland responds rapidly to pulses of ACTH, with pulsatile activation of the 222 
steroidogenic pathway in vivo in the rat that parallels pulsatile secretion of CORT, 223 
this dynamic response is absent when an identical dose of ACTH is infused at a 224 
constant rate (Spiga, et al. 2011b). Moreover, the responsiveness of the adrenal 225 
gland to a pulse of ACTH equivalent to that seen during an acute stress response is 226 
also reduced in rats infused with constant ACTH (Spiga and Lightman 2015). These 227 
observations suggest that the adrenal is adapted to respond rapidly to individual 228 
pulses of ACTH, and that optimal adrenal responsiveness depends on pulsatile 229 
ACTH. We have now begun to dissect the mechanisms underlying this phenomenon 230 
by investigation of the dynamics of the adrenal steroidogenic pathway.  231 
ACTH induces CORT synthesis by activating its specific cell surface G-protein-232 
coupled receptor, the melanocortin type-2 receptor (MC2R; (Mountjoy, et al. 1994)). 233 
ACTH binding to MC2R leads to activation of adenylyl cyclase, followed by an 234 
increase in intracellular levels of cyclic adenosine mono phosphate (cAMP), which in 235 
turn activates downstream signaling pathways including the protein kinase A (PKA) 236 
pathway. Since CORT cannot be stored within adrenal cells, the rapid synthesis of 237 
CORT that occurs within minutes upon ACTH stimulation in vivo, must depends on 238 
ACTH-induced non-genomic events that include post-translational modification of 239 
steroidogenic proteins. This includes phosphorylation of proteins involved in 240 
cholesterol metabolism, notably including hormone soluble lipase (HSL) and 241 
steroidogenic acute regulatory protein (StAR), which regulate the levels of 242 
intracellular cholesterol and its transport within the mitochondria matrix, respectively 243 
(Kraemer and Shen 2002; Lin, et al. 1995). In addition to these rapid non-genomic 244 
events, ACTH also regulates the transcription of genes encoding for steroidogenic 245 
proteins, including StAR, CYP11A (the gene encoding for the cholesterol side-chain 246 
cleavage cytochrome protein P450scc (Churchill and Kimura 1979), which catalyses 247 
the cleavage of the cholesterol side chain to produce pregnenolone in the 248 
mitochondria), and MRAP (the gene encoding for the melanocortin receptor 249 
accessory protein MRAP, which regulates the level and activity of MC2R at the cell 250 
surface, and thus the cell's responsiveness to ACTH (Metherell, et al. 2005)). We 251 
have shown that StAR, CYP11A and MRAP mRNA are normal in rats infused with 252 
pulsatile ACTH, but actually decrease in rats infused with constant ACTH (Spiga, et 253 
al. 2011c).  254 
Studies investigating the effects of a single ultradian pulse of ACTH on the dynamics 255 
of steroidogenic gene transcription in relationship to the dynamics of CORT secretion 256 
in the rat show that the adrenal steroidogenic pathway is highly dynamic in response 257 
to a pulse of ACTH, with rapid changes in the levels of StAR, CYP11A1 and MRAP 258 
transcription, measured as changes in levels of heteronuclear RNA (hnRNA), 259 
peaking 15 min after ACTH administration, and returning to basal levels within 30 260 
min (Liu, et al. 2013; Spiga, et al. 2011a). It is well known that transcription of StAR 261 
and other steroidogenic genes is regulated by the phosphorylation of CREB and 262 
subsequent CREB binding to the CREB responsive element (CRE) with the target 263 
gene promoter. Consistent with this, we found that the dynamic transcriptional 264 
activation of StAR in response to a pulse of ACTH was associated with rapid and 265 
transient phosphorylation of CREB, and rapid dephosphorylation and nuclear 266 
translocation of the CREB co-activator, transducer of regulated CREB activity 2 267 
(TORC2, also called CRTC2) (Takemori, et al. 2007), both occurring 5 min after 268 
administration of the ACTH pulse.  269 
These findings show that pulsatile events leading to the dynamic transcription of 270 
steroidogenic genes in the adrenal gland parallel the pulsatile secretion of CORT. 271 
We propose that pulsatile ACTH results in pulsatile expression of StAR, and other 272 
steroidogenic genes such as MRAP, throughout the circadian cycle, and therefore 273 
increase in both the amplitude of ACTH pulses, and/or responsiveness of the adrenal 274 
to ACTH during the circadian peak will lead to increased amplitude in pulsatile 275 
transcription of steroidogenic genes, ultimately resulting in the circadian variation in 276 
steroidogenic proteins levels that we have observed (Figure 3) (Park, et al. 2013). In 277 
addition to StAR, several transcription factors involved in StAR's transcriptional 278 
regulators, including the positive regulators steroidogenic factor 1 (SF-1; (Caron, et 279 
al. 1997)) and Nur77 (NR4A1; (Martin, et al. 2008)), and the negative regulator DAX-280 
1 (dosage sensitive sex-reversal (DSS), adrenal hypoplasia congenita (AHC) locus 281 
on the X-chromosome; (Jo and Stocco 2004)) are also rhythmically expressed in the 282 
adrenal gland (Park et al. 2013). Interestingly, the pattern of expression of SF-1, 283 
Nur77 and DAX-1 is consistent with their role in regulating the expression of adrenal 284 
StAR: while SF-1 and Nur77 mRNA and protein levels are elevated when StAR 285 
expression reach its circadian peak, the levels of expression of DAX-1 are high when 286 
StAR expression is low. Given that ACTH inhibits DAX-1 transcription, the circadian 287 
increase in ACTH levels decreases DAX-1 expression, thus reducing its inhibitory 288 
effect on StAR transcription. The resulting increase in StAR expression in turn 289 
contributes to increased CORT levels during the circadian peak. It is interesting that 290 
in rats in which the CORT circadian rhythm has been disrupted by chronic exposure 291 
to constant light, the circadian rhythm of StAR and its transcriptional regulators is 292 
also disrupted (Park et al. 2013), further supporting our hypothesis that the pattern of 293 
steroidogenic activity is crucial for maintaining optimal rhythmicity of CORT secretion.  294 
 295 
Intra-adrenal glucocorticoid-mediated negative feedback 296 
Our work implicates a key role for rapid CORT feedback of CRH-induced ACTH 297 
secretion from the pituitary in regulating the ultradian activity of the system.  Since 298 
the adrenal cortex expresses GR, as shown by studies both in rodents (Loose, et al. 299 
1980) and man (Briassoulis, et al. 2011), it is plausible to hypothesize that CORT 300 
may affect its own synthesis by a local feedback mechanism within the adrenal itself.  301 
There is evidence that CORT can indeed affect steroids synthesis in both the adrenal 302 
and other steroidogenic organs including the gonads.  With respect to the effect of 303 
CORT on the adrenal steroidogenic activity, a number of in vitro and in vivo studies 304 
have shown a decrease in adrenal responsiveness following prior exposure to 305 
stressors or ACTH. For example, experiments in cultured adrenal cells have shown 306 
that ACTH-induced CORT synthesis is rapidly inhibited (within 1-2 hours) when 307 
CORT is added to the medium at high concentration (Carsia and Malamed 1979; 308 
Peron, et al. 1960). This is in accordance with studies in vivo in the rat showing that 309 
previous exposure to a stressor, or to a high concentration of ACTH, inhibits CORT 310 
synthesis in response to further stimuli (Jones and Stockham 1966; Langecker and 311 
Lurie 1957), suggesting that CORT synthesis is dependent on the prior state of 312 
adrenal activity.  313 
The molecular mechanism underlying CORT-mediated inhibition of steroidogenesis 314 
is not clear, but there is evidence that the synthetic glucocorticoid dexamethasone 315 
can inhibit the transcription of steroidogenic genes through a mechanism that 316 
involves GR-mediated transcriptional regulation of steroidogenic genes (Gummow, et 317 
al. 2006). Following ACTH stimulation and activation of CREB, StAR expression is 318 
up-regulated by the CREB co-activator SF-1, and inhibited by the co-repressor DAX-319 
1. Interestingly, ACTH can induce the transcription of SF-1 (Ragazzon, et al. 2006) 320 
and Nur77 (Davis and Lau 1994), while inhibiting the transcription of DAX-1 321 
(Ragazzon et al. 2006). Gummow and colleagues have shown that dexamethasone 322 
can induce DAX-1 transcription by a mechanism that involves the formation of an SF-323 
1/GR complex (Gummow et al. 2006), thus leading to inhibition of StAR transcription 324 
and ultimately to inhibition of CORT synthesis. In addition to this, CORT can repress 325 
the transcription of StAR by inhibiting both the transcription and the activity of Nur77 326 
via a mechanism that involves active GR (Martin and Tremblay 2008; Song, et al. 327 
2004). In contrast to this, it has also been shown that, when overexpressed in vitro, 328 
DAX-1 can also enhance steroidogenic gene expression (Xu, et al. 2009), and a 329 
more recent study has shown that prolonged incubation of the human adrenocortical 330 
cell line H295R with dexamethasone can indeed increase both StAR transcription 331 
and CORT production (Asser, et al. 2014). Taken together, these studies motivate 332 
the hypothesis that dynamic secretion of CORT may be regulated by a fine balance 333 
between ACTH-mediated positive feedforward (involving up-regulation and activation 334 
of steroidogenic proteins, and CORT-mediated negative feedback within the adrenal 335 
(involving GR-mediated inhibition of StAR transcriptional regulators, and up-336 
regulation of StAR repressors). It is therefore possible that pulsatile CORT synthesis 337 
observed in the adrenal in response to pulsatile ACTH stimulation may in turn be 338 
able to dynamically regulate the adrenal response to the steroidogenic stimulus. 339 
Furthermore, we have also hypothesized that when CORT secretion is elevated, as 340 
seen for example during a stress response or in certain conditions of disease or 341 
critical illness, this regulatory intra-adrenal feedforward-feedback mechanism may 342 
become disrupted, contributing further to abnormal CORT secretion. 343 
To investigate this hypothesis further, in (Walker, et al. 2015) we considered the 344 
evidence for four candidate mechanisms of adrenal CORT production by studying 345 
their ability to reproduce the dynamics of the system in three experimental 346 
paradigms: (1) administration of an ultradian ACTH pulse; (2) constant infusion of 347 
CRH; and (3) exposure to noise stress. Our findings provide strong evidence for the 348 
existence of a mechanism by which CORT can inhibit its own synthesis and/or 349 
secretion, and further that this mechanism may be transiently blocked during the 350 
early stage of an ACTH pulse. Our hypothesis is that this permits the system to 351 
respond rapidly to incoming stressors, whilst preventing uncontrolled release of 352 
glucocorticoids. The molecular basis of this “systems level” mechanism remains an 353 
open question.   354 
Because our mathematical model predicts that pulsatile CORT can modulate intra-355 
adrenal CORT levels very rapidly, this suggests that, in addition to the genomic 356 
effects of CORT on StAR transcription already discussed, CORT can also regulate 357 
its own synthesis presumably by interfering with non-genomic mechanisms within the 358 
adrenal steroidogenic pathway, for example by regulating the activity (e.g. 359 
phosphorylation/dephosphorylation) of steroidogenic proteins including StAR and 360 
HSL (Figure 5). 361 
Rapid non-genomic effects of CORT at the anterior pituitary have been shown to 362 
involve annexin 1 (ANXA1), a protein that, upon CORT stimulation, is able to 363 
translocate from the cytoplasm to the outer cell surface where it exerts its regulatory 364 
effects, including inhibition of ACTH secretion from intracellular vesicles (Taylor, et 365 
al. 1995). Interestingly, ANXA1 is also expressed in the adrenal cortex, and as 366 
observed in other tissue, its expression and activity is regulated by CORT (Davies, et 367 
al. 2007). Remarkably, the same study also showed that ACTH stimulation of 368 
isolated adrenal gland obtained from ANXA1-null mice exhibited a greater CORT 369 
response compared to adrenal obtained from wild-type mice, suggesting an 370 
involvement of ANXA1 in the inhibition of CORT synthesis. Whether ANAX1 is 371 
involved in rapid CORT-mediated intra-adrenal negative feedback within the time-372 
scale of an ultradian pulse, however, remains to be elucidated.  373 
In summary, our mathematical modelling work suggests that an intra-adrenal 374 
inhibition mechanism of CORT synthesis does indeed exist, and importantly, our 375 
model predictions suggest that this rapid intra-adrenal inhibition is an important factor 376 
regulating CORT synthesis over the timescales of both the basal ultradian rhythmicity 377 
of the HPA axis and the rapid CORT response to stress. In addition to this, our model 378 
points to the existence of a short time delay in this intra-adrenal inhibition, and that 379 
upon ACTH stimulation, this local negative feedback mechanism is rapidly 380 
antagonized, presumably via ACTH activation of the steroidogenic pathway. Our 381 
hypothesis is that these feedforward-feedback mechanisms of intra-adrenal 382 
regulation enable rapid glucocorticoid release while at the same time prevent 383 
uncontrolled release of glucocorticoids in response to large surges in ACTH 384 
associated with stress or diseased states. 385 
 386 
Ultradian rhythm of glucocorticoids in human disease and critical illness 387 
The release of ACTH and CORT in man is also characterized by an ultradian rhythm 388 
with a close temporal relationship between pulses of ACTH and CORT, as has been 389 
observed in the rat, lending further support to our hypothesis that pulsatile ACTH is 390 
crucial for maintaining physiological pulsatility of CORT. Furthermore, consistent with 391 
changes in the pulsatile pattern observed in a number of disease models in the rat 392 
(e.g. chronic inflammation and chronic exposure to constant light), a similar 393 
disruption of cortisol pulsatility has been reported in chronic illness in man. For 394 
example, an elevation in CORT secretion due to an increase in the mass of CORT 395 
pulses has been observed in patients affected by obstructive sleep apnea, and a 396 
complete remission of these hormonal changes was achieved following medical 397 
treatment of the condition (Henley, et al. 2009b).  398 
Given that the ultradian rhythm of CORT secretion is crucial for normal physiological 399 
functions, it is therefore clear that any disruption in the pulsatile pattern of hormone 400 
release could lead to impairment of CORT-regulated functions, including metabolic 401 
processes and the immune response. Indeed, maintenance of a normal ultradian 402 
rhythm of cortisol is particularly important in major surgery and critical illness 403 
(reviewed in (Gibbison, et al. 2013)). In this regard, a recent study from our group in 404 
which the pattern of CORT secretion was investigated in patients undergoing cardiac 405 
surgery showed that a disruption in CORT secretion occurs in these patients, with 406 
high CORT levels, despite normal ACTH, observed for several hours after the 407 
termination of the surgical procedure through the recovery period (Gibbison B 2015; 408 
Gibbison, et al. 2015). These data suggest that dissociation between ACTH and 409 
CORT occurs in these patients. It is important to highlight that in these patients both 410 
ACTH and CORT still display a pulsatile pattern of secretion, suggesting that 411 
although the adrenal sensitivity to ACTH may be altered, the mechanisms regulating 412 
pulsatility, including the dynamics of adrenal steroidogenesis, as well as the negative 413 
feedback mechanisms at the levels of the pituitary, are maintained. It is also 414 
noteworthy to point out that, because a delay between the beginning of the surgery 415 
and the onset of the ACTH response was observed, it is likely that the HPA axis 416 
response in these patients may not be induced by the anesthesia or the surgical 417 
procedure itself, but other factors may be d involved in the robust hormonal response 418 
observed. For example, the time of the ACTH response in these patients is 419 
consistent with the time of increase in circulating inflammatory mediators (including 420 
TNF, IL-1 and IL-6) that also remain elevated for about 24 hours before returning to 421 
normal levels (de Mendonca-Filho, et al. 2006; Lahat, et al. 1992; Roth-Isigkeit, et al. 422 
1999). It is known that circulating cytokines can activate CORT secretion not only via 423 
inducing hypothalamic CRH and pituitary ACTH release, but also by acting directly at 424 
the level of the adrenal gland (Engstrom, et al. 2008). Indeed, cytokine receptors are 425 
expressed in the zona fasciculata of the adrenal cortex, and an increase in cytokines 426 
in the adrenal can therefore potentiate the effects of ACTH, as well as exert a direct 427 
effect on steroidogenesis, through a mechanism that involves an increase in the 428 
expression of steroidogenic genes, including StAR (Tkachenko, et al. 2011). In 429 
addition, because pathogens can induce the expression of a number of cytokines in 430 
the adrenal gland itself through activation of toll-like receptors expressed in the 431 
adrenal, an immune-adrenal cross talk regulating CORT synthesis has also been 432 
suggested (Judd, et al. 2000; Zacharowski, et al. 2006). Therefore, the mechanisms 433 
underlying the dissociation between ACTH and CORT secretion and increased 434 
adrenal sensitivity that we have observed in our clinical studies may involve 435 
circulating and/or intra-adrenal cytokines.  436 
We further investigated the hypothesis of an involvement of inflammatory mediators 437 
in the increased adrenal sensitivity to ACTH observed in our studies using a well-438 
established rat model of acute critical illness (administration of lipopolysaccharide, 439 
LPS). The hormonal response to an acute injection of LPS in the rat is similar to what 440 
we observe in humans undergoing cardiac surgery. Following a rapid initial HPA axis 441 
activation, ACTH levels return to normal within 4 hours of LPS administration, 442 
whereas plasma CORT levels remain high for several hours. Since CORT secretion 443 
is tightly regulated buy the pattern of ACTH under basal conditions, our data suggest 444 
that LPS injection increases adrenal sensitivity to ACTH. Interestingly, when rats are 445 
injected with a high dose of ACTH that produces plasma ACTH levels (and pattern) 446 
similar to those observed after LPS administration, CORT levels return to basal 447 
shortly after the decline of ACTH (Gibbison et al. 2015) further supporting our 448 
hypothesis that factors other than ACTH are responsible for the increased adrenal 449 
sensitivity observed both in our clinical and experimental studies. Consistent with the 450 
above discussed role of cytokines in adrenal steroidogenesis, we observed that the 451 
sustained increase in CORT levels in rats injected with LPS was paralleled by 452 
increased intra-adrenal CORT levels and increased expression of steroidogenic 453 
genes including StAR and MRAP, suggesting an LPS-induced increase in adrenal 454 
steroidogenic activity. The mechanism by which cytokines affect steroidogenic gene 455 
expression has not yet been elucidated, however we also found that the increase in 456 
steroidogenic gene expression was associated with a dramatic decrease in DAX-1 457 
protein expression. In accordance with a lack of sustained increase in CORT, we did 458 
not find such effects on steroidogenic genes in rats injected with a high dose of 459 
ACTH (Spiga and Lightman 2015). In summary, both our clinical and experimental 460 
studies show that a robust dissociation between ACTH and CORT occurs in 461 
conditions of critical illness, and our data from the rat suggest that the changes in the 462 
adrenal steroidogenic pathway underlying the increase in adrenal sensitivity may not 463 
be induced by the initial peak in ACTH that occurs after surgery (man) or LPS (rat), 464 
but by inflammatory factors within the adrenal cortex that may act to regulate CORT 465 
release. 466 
This hypothesis is further supported by recent data from Boonen and colleagues, 467 
showing that patients with sustained critical illness also have elevated levels of 468 
CORT, and interestingly, the same study shows that there is a positive correlation 469 
between high levels of cytokines and high levels of CORT in these patients (Boonen, 470 
et al. 2014). Furthermore, the same investigators have observed that patients with 471 
prolonged critical illness have low levels of ACTH, presumably as a result of 472 
increased negative feedback induced by elevated cortisol levels, and this is also 473 
associated with alterations in the adrenal steroidogenic pathway including 474 
cholesterol-ester depletion as well as reduction in ACTH-regulated steroidogenic 475 
gene expression, including MC2R and StAR (Boonen et al. 2014). This is in contrast 476 
to our hypothesis that increased adrenal responsiveness in critical illness is 477 
associated with increased steroidogenic activity in the adrenal. However, these 478 
effects on adrenal gene expression observed in sustained critical illness are 479 
presumably the consequence of prolonged ACTH depletion observed in these 480 
patients, and are consistent with the adrenal alterations observed in mice lacking 481 
POMC, the gene that encodes for the precursor of ACTH (Karpac, et al. 2008). 482 
Taken together, these observations suggest that in acute critical illness that is 483 
associated with an inflammatory response, cytokines and other immune-modulators 484 
may be responsible for elevated plasma levels of CORT. In contrast, in prolonged 485 
critical illness, high levels of plasma CORT may be due to other mechanisms, 486 
including reduced CORT metabolism (Boonen, et al. 2013). 487 
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Figure legend 
Figure 1. The HPA axis and glucocorticoid ultradian rhythm. (a) Stress and 
circadian inputs activate the hypothalamic PVN to releases CRH and AVP into the 
hypothalamic–pituitary portal circulation. CRH and AVP activate corticotroph cells in 
the anterior pituitary, which respond with the rapid release of ACTH into the general 
blood circulation. In turn, ACTH reaches the adrenal gland where it activates the 
synthesis of glucocorticoid hormones (CORT) via which they reach target tissues. 
Glucocorticoids regulate the activity of the HPA axis, and thus their own production, 
through feedback mechanisms acting at the level of the pituitary gland where they 
inhibit ACTH release, and at the level of the PVN where they inhibit the release of 
CRH and AVP. (b) Under basal (i.e. unstressed) conditions, CORT levels are 
characterized by both a circadian and an ultradian rhythm. The data represent an 
example of 24-hour profile of plasma CORT from adult male rat. Shaded region 
indicates the dark phase. Data adapted from (Walker et al. 2012). 
Figure 2. Response of the pituitary–adrenal system to different patterns of CRH 
drive. Model predictions of CORT pulsatility for constant CRH (a), pulsatile CRH (b) 
and circadian CRH (c). Response demonstrates a frequency in CORT governed by 
the pituitary–adrenal system and not by the frequency of the CRH forcing. Data 
adapted from (Walker et al. 2010). 
Figure 3. Model of dynamic expression of steroidogenic genes. Pulsatile ACTH 
induces dynamic transcription of StAR (hnRNA); circadian variation in ACTH pulse 
amplitude, as well as circadian variation in adrenal responsiveness to ACTH, 
determine changes in the amplitude of StAR hnRNA pulses leading to circadian 
expression of StAR protein. Model based on data adapted from (Carnes et al. 1988a; 
Park et al. 2013; Spiga et al. 2011a). 
Figure 4. Dynamics of human ACTH and cortisol in health and disease. (a) 
Individual 24-hour ACTH and cortisol profile of a healthy volunteer. ACTH and 
cortisol both display a tightly correlated ultradian rhythm. Data adapted from 
(Gibbison et al. 2015; Henley et al. 2009a) (b) Dynamics of cortisol and ACTH 
secretion throughout the 24-hour perioperative period of cardiac surgery. After the 
initial surge of ACTH and cortisol, both ACTH and cortisol continue to pulse. 
However, while both the absolute values of ACTH and the pulse amplitude are 
reduced, the cortisol levels remain elevated. The gray area represents the period of 
surgery. Data adapted from (Gibbison et al. 2015; Henley et al. 2009a). 
Figure 5. Modell hypothesis of glucocorticoid-mediated regulation of the 
adrenal steroidogenic network. ACTH binding to it specific receptor MC2R induces 
rapid glucocorticoid secretion by PKA-mediated non-genomic regulation of 
steroidogenic proteins involved in cholesterol metabolism. This includes 
phosphorylation of hormone sensitive lipase (HSL), a protein that increases the 
levels of intracellular cholesterol (the precursor of steroid hormones), and 
phosphorylation of steroidogenic acute regulatory protein (StAR), which promotes the 
transport of cholesterol into the mitochondria, where cholesterol is converted into 
pregnenolone by the enzyme side-chain cleavage cytochrome P450. PKA also 
mediates adrenal genomic activity by inducing the transcription of genes encoding for 
steroidogenic proteins, including StAR. Our mathematical modelling work suggests 
that CORT regulates an intra-adrenal inhibition mechanism of CORT synthesis that 
an important factor regulating CORT synthesis over the timescales of both ultradian 
rhythm and the rapid response to stress. It is therefore our hypothesis that CORT 
may regulate the steroidogenic response by acting both at a genomic level (e.g. by 
regulating steroidogenic genes transcription), as well as at non-genomic levels by 
regulating the phosphorylation of steroidogenic proteins such as StAR and HSL. 
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